THE PSYCHOMETRIC PROPERTIES OF A RUSSIAN VERSION OF THE DISEASE-SPECIFIC LUPUSQOL QUESTIONNAIRE ASSESSING THE HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Objective: to assess the reliability, validity, and sensitivity of a Russian version of the LupusQol questionnaire.Subjects and methods. The investigation enrolled 328 patients aged 18 years or older with systemic lupus erythematosus (SLE) who met the 2012 Systemic Lupus International Collaborating...

Full description

Bibliographic Details
Published in:	Научно-практическая ревматология
Main Authors:	E. A. Aseeva, L. D. Vorobyeva, S. K. Solovyev, V. N. Amirdzhanova, S. I. Glukhova, G. M. Koilubaeva, M. V. Letunovich
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2018-05-01
Subjects:	systemic lupus erythematosus health-related quality of life lupusqol sf-36 specific questionnaires
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2521

Similar Items

SELECTION OF AN OPTIMAL HEALTH-RELATED QUALITY-OF-LIFE QUESTIONNAIRE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: L. D. Vorobyeva, et al.
Published: (2018-11-01)

IMPACT OF THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (ACCORDING TO THE RENAISSANCE REGISTER)
by: L. D. Vorobyeva, et al.
Published: (2019-09-01)

Patient-reported outcome measures for lupus nephritis: content validity of LupusQoL and FACIT-Fatigue
by: Mona L. Martin, et al.
Published: (2024-09-01)

QUALITY-OF-LIFE ISSUES IN THE COMPREHENSIVE EXAMINATION OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: S. T. Abisheva, et al.
Published: (2014-09-01)

Health-related quality of life impairment is equal for antiphospholipid syndrome whether primary or associated with systemic lupus erythematosus
by: Ewa Haladyj, et al.
Published: (2024-09-01)

Evaluating the Validity and Reliability of Persian Version of Lupus Quality of Life (LupusQol) Questionnaire in Iranian Patients
by: Naeimehossadat Hosseini, et al.
Published: (2014-01-01)

Changes in Quality of Life Domains among Saudi Patients with Systemic Lupus Erythematosus before and during the COVID-19 Pandemic
by: Howeida Abusalih, et al.
Published: (2024-12-01)

Importance of health-related quality of life and its current assessment tools in patients with systemic lupus erythematosus
by: L. D. Vorobyeva, et al.
Published: (2018-01-01)

Quality of life in patients with systemic lupus erythematosus
by: Елена Александровна Асеева, et al.
Published: (2013-06-01)

Irreversible organ damages in a cohort of patients with systemic lupus erythematosus (RENAISSANCE)
by: E. A. Aseeva, et al.
Published: (2016-10-01)

THE REGISTRY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS, A EURASIAN COHORT (RENAISSANCE)
by: E. A. Aseeva, et al.
Published: (2016-12-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

Possibilities and prospects for glucocorticoid withdrawal in systemic lupus erythematosus
by: S. K. Solovyev, et al.
Published: (2020-03-01)

Characteristics of systemic lupus erythematosus in patients of Asian ethnicity
by: G. M. Koilubaeva, et al.
Published: (2025-02-01)

Forecasting index of unfavorable outcomes of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2021-06-01)

The problem of fatigue in patients with systemic lupus erythematosus according to the data on a Russian RENAISSANCE cohort
by: E. A. Aseeva, et al.
Published: (2020-11-01)

Cutaneous lupus erythematosus: An update
by: Carina M Grönhagen, et al.
Published: (2014-01-01)

Systemic lupus erythematosus: new horizons for diagnosis and therapy
by: S. K. Solovyev, et al.
Published: (2020-02-01)

Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus
by: Man Chu, et al.
Published: (2015-10-01)

Rapid clearance of cutaneous lesions with anifrolumab in SLE (systemic lupus erythematosus) and DLE (discoid lupus erythematosus)
by: E. Parriel, et al.
Published: (2025-03-01)

Clinical manifestations, courses, and outcomes of systemic lupus erythematosus in the dwellers of Kyrgyzstan
by: G. M. Koilubaeva, et al.
Published: (2016-10-01)

Clinical and immunological phenotypes of systemic lupus erythematosus, identified based on cluster analysis of data from 400 patients from V.A. Nasonova Research Institute of Rheumatology
by: E. A. Aseeva, et al.
Published: (2022-10-01)

Drug-induced lupus erythematosus
by: Ana L. Gouveia, et al.
Published: (2023-07-01)

Anti-B cell therapy in patients with systemic lupus erythematosus
by: M. E. Tsanyan, et al.
Published: (2018-01-01)

Validity and Reliability of the Indonesian Version of SF-36 Quality of Life Questionnaire on Patients with Permanent Pacemakers
by: Simon Salim, et al.
Published: (2017-05-01)

Validity and Reliability of the Indonesian Version of SF-36 Quality of Life Questionnaire on Patients with Permanent Pacemakers
by: Simon Salim, et al.
Published: (2017-05-01)

Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus
by: N. Yu. Nikishina, et al.
Published: (2025-06-01)

SF-36 questionnaire population quality of life indices Objective
by: V N Amirdjanova, et al.
Published: (2008-02-01)

Flare of bullous lupus erythematosus in patients treated with anifrolumab for discoid lupus erythematosus: 2 cases
by: Cécile Lesort, MD, et al.
Published: (2025-04-01)

Genetically engineered biological agents in therapy for systemic lupus erythematosus
by: Elena Aleksandrovna Aseeva, et al.
Published: (2013-10-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

Specific features of regulatory T cells in patients with systemic lupus erythematosus
by: A. V. Torgashina, et al.
Published: (2018-12-01)

Difficulties in diagnostics of systemic lupus erythematosus
by: N. V. Zilberberg, et al.
Published: (2021-06-01)

Clinical features of systemic lupus erythematosus in men depending on testosterone level
by: T. S. Panevin, et al.
Published: (2025-04-01)

Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects
by: Everton Carlos Siviero do Vale, et al.
Published: (2023-06-01)

Direct immunofluorescence in Lupus Erythematosus (LE)
by: Roseli Svartman Isfer, et al.

Clinical and immunologic features of the phenotype of systemic lupus erythematosus combined with Sjögren's syndrome
by: S. K. Solovyev, et al.
Published: (2023-08-01)

THE EFFICIENCY OF BIOLOGICAL THERAPY AND THE FEATURES OF HUMORAL IMMUNITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: A. A. Mesnyankina, et al.
Published: (2018-07-01)

Cutaneous lupus erythematosus of elbows: A distinct entity?
by: Nidhi Singh, et al.
Published: (2016-01-01)

LUNG INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: WELL-KNOWN FACTS AND UNSOLVED ISSUES
by: N. G. Klyukvina, et al.
Published: (2016-12-01)